Physician profile
John M Rootring
NPI 1598768392
$4,864.30
in general payments reported to CMS, 2019-2025
26 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,498 · 2020: $413 · 2021: $743 · 2022: $770 · 2023: $849 · 2024: $391 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,439.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,257.05 | 2019-2025 | Allowrap, Viaflow, Augment Injectable |
| Smith+Nephew, INC. | $450.50 | 2019-2023 | Grafix |
| Treace Medical Concepts, INC. | $296.76 | 2022-2023 | |
| Rikco International, LLC | $173.00 | 2019 | |
| Kci USA, INC. | $123.58 | 2019 | |
| Paratek Pharmaceuticals, INC. | $117.79 | 2022-2025 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $44.38 | 2021-2024 | Jublia |
| Organogenesis INC. | $39.10 | 2019-2022 | |
| Solventum Corporation | $37.90 | 2025 | Activ.A.C. |
| Zimmer Biomet Holdings, INC. | $30.00 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $29.78 | 2019 | |
| Convatec INC. | $28.98 | 2023-2024 | |
| Paragon 28, INC. | $24.66 | 2019 | |
| Acera Surgical, INC. | $22.00 | 2025 | Restrata Wound Matrix |
| Cashflow Solutions, LLC | $19.91 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $19.09 | 2025 | Flexitouch Plus, Nimbl |
| Medtronic, INC. | $18.30 | 2022 | |
| Abbvie INC. | $17.02 | 2022 | |
| Averitas Pharma INC. | $16.32 | 2025 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $16.24 | 2022 | |
| Nevro Corp. | $15.06 | 2022 | |
| Reprise Biomedical, INC. | $14.43 | 2025 | Miro 3d |
| Amgen INC. | $14.05 | 2025 | Krystexxa |
| Trice Medical, INC. | $13.16 | 2023 | |
| Horizon Therapeutics Plc | $12.70 | 2021 | |
| Melinta Therapeutics, LLC | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rootring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.